Guangzhou, China

Chao Qin

This inventor holds 6 USPTO granted patents and 4 published patent applications. Top assignees: Bio-Thera Solutions, Ltd., Bio-Thera Solutions, Ltd., Co.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chao Qin. Retrieved from https://idiyas.com/inventor/chao-qin-19lpitkf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Science City, CN (2021)
  • Guangzhou, CN (2014 - 2022)

Company Filing History:


Years Active: 2014-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Chao Qin in Bioengineering

Introduction

Chao Qin is a prominent inventor based in Guangzhou, China, known for his significant contributions to the fields of bioengineering and biotechnology. With a total of 6 patents, he has made remarkable advancements that have the potential to impact medical treatments and diagnostics.

Latest Patents

One of his latest patents is titled "Recombinant antibody having unique glycan profile produced by CHO host cell with edited genome and preparation method thereof." This invention focuses on a method for preparing a recombinant antibody with a unique glycan profile produced by genome-edited CHO host cells. The method utilizes TALEN technology to edit the FUT8 gene in CHO cells adapted for serum-free suspension growth. The resulting edited CHO host cells can produce antibodies characterized by non-fucosylated N-linked oligosaccharide chains, low N-glycosylation heterogeneity, and uniform carbohydrate chains. These antibodies exhibit significantly increased antibody-dependent cellular cytotoxicity (ADCC) and greater stability.

Another notable patent is "Compounds and methods for the treatment of TROP2 positive diseases." This invention relates to compounds that include antibodies and antigen-binding fragments that bind to TROP2 (TACSTD2). It also encompasses methods for using these TROP2-binding molecules for diagnosing and treating diseases, including various malignancies.

Career Highlights

Chao Qin has worked with Bio-Thera Solutions, Ltd., a company recognized for its innovative approaches in biopharmaceuticals. His work there has contributed to the development of cutting-edge therapies and has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Chao Qin has collaborated with notable professionals, including Weijia Tang and Shengfeng Li. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Chao Qin's contributions to bioengineering and biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and diagnostics, showcasing the importance of innovation in improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…